Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Morgan Stanley Plans Reducing Senior Pay 20-30%: Bloomberg

RELATED NEWS
Trade MS now with 

Morgan Stanley (MS: Quote) is reducing pay for senior investment bankers and traders by an average of 20 to 30 percent for 2011, Bloomberg said citing people with knowledge of the decision.

The pay cuts will reportedly affect employees on the executive director level and above.

The investment banking giant's decision is said to be part of it effort to curb mounting compensation costs. Earlier this week, reports said that the company is planning to reduce employee bonuses sharply and to restrict cash payouts to $125,000.

The company also intends to defer payout for 2011 to as far as the end of this year, after a quarter saw weakness in trading and investment banking businesses in general.

On Thursday, Morgan Stanley reported a loss for the fourth quarter, reflecting a $1.7 billion settlement with bond insurer MBIA Inc. to resolve lawsuits related to credit default swaps and a 40 percent drop in investment banking revenues. Investment banking revenues dropped 40 percent to $1.05 billion, while trading revenues grew by 13 percent to $969 million.

Financial services firms in general have suffered in terms of trading and investment banking revenue in the fourth quarter. JP Morgan Chase & Co. (JPM) last week reported a 30 percent fall in investment banking revenue.

Goldman Sachs Group, Inc. (GS) also reported a 56 percent decline in profit for the fourth quarter, reflecting a drop in investment banking revenue due to the weak capital markets and Europe's ongoing debt crisis.

MS closed Thursday's regular trading at $18.28, up 5.36 percent on the NYSE.

Register
To receive FREE breaking news email alerts for Morgan Stanley and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Micro-blogging site Twitter Inc said Tuesday after the markets closed that its second quarter loss widened from last year, hurt mainly by stock-based compensation expense, even as revenue more than doubled thanks to growth in advertising. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Pharmaceutical giant Pfizer, Inc., which was aspiring to buy British drug maker AstraZeneca Plc, reported Tuesday a profit for the second quarter that plunged 79 percent from last year, which reflected hefty gains from animal health business sales. Total revenues declined 2 percent, as it continued to be hurt by generic competition for major drugs. Home improvement and building products company Masco Corp. said Monday after the markets closed that its second quarter profit jumped 78% from last year, as revenue increased and margins improved amid strong performance of its Plumbing Products, Installation and Other Services and Decorative Architectural Products segments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.